Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion type Assertion NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_head.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion description "[HLA-A*0201 decreases the overall risk (odds ratio= 0.52) and the presence of A*0201 reduces the risk of MS for DRB1*15,DQB1*06 carriers from 3.6 to 1.5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_provenance.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion evidence source_evidence_literature NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_provenance.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion SIO_000772 10746785 NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_provenance.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion wasDerivedFrom befree-20140225 NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_provenance.
- NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_assertion wasGeneratedBy ECO_0000203 NP349388.RAt6cQ4EIpMG-bw3RnwZOavNXVq6xxYmPGqRqIusSj_60130_provenance.